| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/14/2006 | US6998385 Antiinflammatory agents; autoimmune disease |
| 02/14/2006 | US6998268 Gene preparations |
| 02/14/2006 | US6998141 Medication combination for hepatoma and pancreatic cancer and preparation protocol |
| 02/14/2006 | US6998140 Use as coating agent and binder for pharmaceutical forms, comprising a methacrylate copolymer of given glass transition temperature range, and a nonionic emulsifier of given hydrophilic-lipophilic balance (HLB); dosage forms |
| 02/14/2006 | US6998139 Multilayer tablet; control releasing |
| 02/14/2006 | US6998138 Benzoic or cinnamoyl ester penetration enhancing agent |
| 02/14/2006 | US6998137 Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix |
| 02/14/2006 | US6998136 Stability for injection solutions |
| 02/14/2006 | US6998128 comprises calcium sulfate regions with differing dissolving rates containing antibiotics, chemotherapeutic agents, growth factors, and analgesics within; pharmacokinetics |
| 02/14/2006 | US6998125 Administering a cytotoxic T-lymphocyte and one agent capable of neutralizing or down regulating the activity of tumor secreted immunosuppressive factors |
| 02/14/2006 | US6998121 Treatment of Dupuytren's contracture, scleroderma, Peyronie's disease, bovine mastistis and claudication due to peripheral arterial disease |
| 02/14/2006 | US6998115 Biodegradable and biocompatible and may be used in a variety of drug delivery systems; suited for the delivery of polynucleotides |
| 02/14/2006 | US6998112 Sleep inducing toothpaste made with natural herbs and a natural hormone |
| 02/14/2006 | US6998110 High speed absorption; mixture of aqueous polar solvent, propellant, active material and flavor |
| 02/14/2006 | US6998109 Emu-based formulations with lidocaine for wound treatment by inhibiting microbial activity |
| 02/14/2006 | US6998107 comprises void containing vapor of volatile liquid perfluorocarbon, combined with aqueous solution to form contrast agent, for oral/rectal administration or injection; for gastrointestinal imaging/tomography |
| 02/14/2006 | US6998074 Method for forming polymer microspheres |
| 02/14/2006 | US6998051 Forming microparticles; dissolving in a solvent; dispersion; solvent extraction from solvent |
| 02/14/2006 | US6997922 Osmotic delivery system having space efficient piston |
| 02/14/2006 | US6997921 Infusion device and driving mechanism for same |
| 02/14/2006 | US6997920 External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities |
| 02/14/2006 | US6997863 Thermotherapy via targeted delivery of nanoscale magnetic particles |
| 02/14/2006 | CA2375385C Propargyl phenyl ether a2a receptor agonists |
| 02/14/2006 | CA2338684C Injectable propofol formulations |
| 02/14/2006 | CA2324493C Controlled release oral tablet having a unitary core |
| 02/14/2006 | CA2308598C Laser beam cutting method for cutting laminates for applying to the skin |
| 02/14/2006 | CA2292586C Solid pharmaceutical dosage forms in form of a particulate dispersion |
| 02/14/2006 | CA2288793C Poly(vinyl alcohol) cryogel |
| 02/14/2006 | CA2223014C Controlled release formulation having a preformed passageway |
| 02/14/2006 | CA2190148C Oral liquid alendronate formulations |
| 02/12/2006 | CA2476101A1 Extended-release capsules comprising venlafaxine hydrochloride |
| 02/09/2006 | WO2006015358A2 Aqueous suspension of nanoscale drug particles from supercritical fluid processing |
| 02/09/2006 | WO2006015299A2 Multi-reservoir device for transdermal drug delivery and sensing |
| 02/09/2006 | WO2006015294A1 A gastric retained dosage form of gabapentin |
| 02/09/2006 | WO2006015120A2 Stable injectable composition of alpha tocopheryl succinate, analogues and salts thereof |
| 02/09/2006 | WO2006014973A2 Pharmaceutical dosage forms including rasagiline |
| 02/09/2006 | WO2006014917A2 Method for coating substrate with antimicrobial agent and product formed thereby |
| 02/09/2006 | WO2006014788A1 Methods of use of herbal compositions |
| 02/09/2006 | WO2006014626A2 Partuculate constructs for release of active agents |
| 02/09/2006 | WO2006014572A1 Delivery system |
| 02/09/2006 | WO2006014524A2 Medical device with low magnetic susceptibility |
| 02/09/2006 | WO2006014256A2 System for generating a bioactive dosage form |
| 02/09/2006 | WO2006014236A1 Delivery system for topical medications |
| 02/09/2006 | WO2006014194A1 Oligosaccharide-containing compositions and uses thereof |
| 02/09/2006 | WO2006013914A1 Preparation for administration to mouth mucosa |
| 02/09/2006 | WO2006013851A1 Device to be used in body cavity and sustained-release preparation |
| 02/09/2006 | WO2006013545A1 Pharmaceutical compositions of irbesartan |
| 02/09/2006 | WO2006013444A1 Preparations of stable pharmaceutical compositions of nateglinide and processes for their preparation |
| 02/09/2006 | WO2006013376A2 Drug delivery of a cox inhibitor from embolic agents |
| 02/09/2006 | WO2006013335A1 Stabilised prostaglandin composition |
| 02/09/2006 | WO2006013309A1 Drug delivery from embolic agents |
| 02/09/2006 | WO2006013080A1 Substituted organopolysiloxanes and use thereof |
| 02/09/2006 | WO2006013060A1 Substituted organopolysiloxanes and use thereof |
| 02/09/2006 | WO2006012723A1 A multiple emulsion excipient for cosmetic actives |
| 02/09/2006 | WO2005112885A3 Oligonucleotide-containing microspheres, their use for the manufacture of a medicament for treating diabetes type 1 |
| 02/09/2006 | WO2005102334A3 Apparatus and method for transdermal delivery of fentany-based agents |
| 02/09/2006 | WO2005065291A3 Enteric coated aliphatic amine polymer bile acid sequestrants |
| 02/09/2006 | WO2005049801A3 Dry protein formulation |
| 02/09/2006 | US20060030950 Prosthetic foot with tunable performance |
| 02/09/2006 | US20060030937 Carrier and kit for intraluminal delivery of active principles or agents |
| 02/09/2006 | US20060030838 Methods and devices for delivering GLP-1 and uses thereof |
| 02/09/2006 | US20060030837 Drug delivery apparatus |
| 02/09/2006 | US20060030836 Automatic dose infusion apparatus and method of controlling the same |
| 02/09/2006 | US20060030801 Patch |
| 02/09/2006 | US20060030694 Antitumor agents; fusion protien increases biological half life |
| 02/09/2006 | US20060030655 Nanoemulsion containing nonionic polymers, and its uses |
| 02/09/2006 | US20060030622 Compounds and methods for the treatment of urogenital disorders |
| 02/09/2006 | US20060030587 Method of treating attention deficit disorders with d-threo methylphenidate |
| 02/09/2006 | US20060030581 Mannitol formulation for integrin receptor antagonist |
| 02/09/2006 | US20060030578 Pharmaceutically active lipid based formulation of irinotecan |
| 02/09/2006 | US20060030540 Transgenic animals produced using oral administration of a genetic agent coupled to a transporting agent |
| 02/09/2006 | US20060030535 Controlled modulation of the pharmacokinetics and biodistribution of aptamer therapeutics |
| 02/09/2006 | US20060030523 Binding to LRP5 or LRP6 receptor; promoting growth with DAN family bone morphogenetic protein antagonist |
| 02/09/2006 | US20060029986 Prevention and treatment of cardiovascular pathologies |
| 02/09/2006 | US20060029719 High-intensity sweetener composition and delivery of same |
| 02/09/2006 | US20060029689 Skin protection composition |
| 02/09/2006 | US20060029687 comprises a carrier essentially formed of water, ethoxydiglycol and propylene glycol; anti-oxidant; high stirring speed provides for micronizaton of the components, which is responsible for the stability of the solutions |
| 02/09/2006 | US20060029682 Treatment of wounds and compositions employed |
| 02/09/2006 | US20060029678 Process for the production of implants |
| 02/09/2006 | US20060029677 Azithromycin dosage forms with reduced side effects |
| 02/09/2006 | US20060029676 Aqueous suspension of nanoscale drug particles from supercritical fluid processing |
| 02/09/2006 | US20060029675 Method for coating substrate with antimicrobial agent and product formed thereby |
| 02/09/2006 | US20060029674 Stable amorphous Cefdinir |
| 02/09/2006 | US20060029673 A device for delivering fesoterodine (fumarate) through the skin in a dosage ofo.r-20 mg per day and is provided in a polymer matrix for uniform release;contact adhesives; sel-adhesives; impermeable backing; flatness; geratrics;drug delivery; side effect reduction |
| 02/09/2006 | US20060029672 Silicone gel composition and dispenser therefor |
| 02/09/2006 | US20060029671 Tablet coating composition |
| 02/09/2006 | US20060029670 Pharmaceutical Formulations and Method for Making |
| 02/09/2006 | US20060029669 Controlled release nateglimide formulation; reducing blood glucose concentration |
| 02/09/2006 | US20060029668 Sustained release L-arginine formulations and methods of manufacture and use |
| 02/09/2006 | US20060029667 Enhanced oral and transcompartmental delivery of therapeutic or diagnostic agents |
| 02/09/2006 | US20060029666 Particle embedded with chemical substances and method of producing a particle |
| 02/09/2006 | US20060029665 Pilocarpine compositions and methods of use thereof |
| 02/09/2006 | US20060029664 Dosage form containing carbetapentane and another drug |
| 02/09/2006 | US20060029663 Solid formulation |
| 02/09/2006 | US20060029662 administering N-ethyl-N'-(3-dimethylaminopropyl) urea; N-ethyl-N'-(3-dimethylaminopropyl) urea methiodide to treat arthritis; antiinflammatory agent |
| 02/09/2006 | US20060029661 Orally administrable pharmaceutical formulation |
| 02/09/2006 | US20060029660 Non-gelatin capsule shell formulation |
| 02/09/2006 | US20060029659 Immune dengue plus |
| 02/09/2006 | US20060029658 Stable sterile filterable liposomal encapsulated taxane and other antineoplastic drugs |
| 02/09/2006 | US20060029657 Topical skin protectant compositions |